What's Driving Injectable Drug Delivery Market Trends? Key Company Profiled In Amgen Inc., Medtronic PLC, West Pharmaceutical Services, Yepsomed, Becton

According to the latest report published by Future Market Insights, titled ‘Global Injectable Drug Delivery Market: Global Industry Analysis 2013–2017 and Opportunity Assessment, 2018–2028’, the Global injectable drug delivery market is expected to expand at a CAGR of 10.9% over the forecast period, 2018–2028.

FMI estimates that the global market for injectable drug delivery was valued at US$ 10,400.0 Mn in 2017 and is expected to expand at CAGR of 10.9% over 2018–2028, to reach US$ 32,136.9 Mn by 2028 end. Based on product type, the needle-free injectable drug delivery segment dominated the global injectable drug delivery market in 2017. Moreover, the subtype, prefilled of needle-free injectors segment is expected to have a dominant share of the needle-free type of injectable drug delivery market due to its ease of application. North America is expected to maintain its dominance in the global injectable drug delivery market due to the presence of a large number of manufacturers of injectable drug delivery devices, mostly operating from the U.S.

Examples of some of the key players identified in the global injectable drug delivery market include Amgen Inc., Medtronic PLC, West Pharmaceutical Services, Yepsomed, Becton, and Dickinson And Company, Antares Pharma, Mylan, SHL Group, Endo International PLC, Crossject, and Consort Medical (Bespak), among others.

Download Sample Copy of Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-393

Increase in prevalence of chronic diseases such as diabetes, cancer and rheumatoid arthritis along with other factors such as need for patient-controlled drug release and increased risk of needle stick injuries are the prominent factors expected to drive the growth of the injectable drug delivery market. Technological advancements have resulted in better product offerings in the injectable drug delivery market. However, some factors such as strict regulatory framework and premium pricing of products are expected to hinder the growth of the injectable drug delivery market. The key trend of the injectable drug delivery market is the increasing demand for point-of-care devices. Injectable drug delivery devices are easy to self-administer and do not require a healthcare professional for administration, which as a result skips the need of hospital visits and relatively lowers the healthcare spending for an individual.

The global injectable drug delivery market has been segmented on the basis of product type, usage, end users and regions. The disposable injectable drug delivery segment is expected to be the most attractive usage segment. Among the three end users, the hospital pharmacies is expected to be the dominant segment due to benefits such as favourable reimbursement policies in most of the countries across the globe.

In terms of value, the global injectable drug delivery market is expected to expand at 10.9% CAGR over the forecast period. With nearly 32% market share, North America was a dominant regional market for injectable drug delivery in 2017, due to growing number of manufacturers in the region and early adoption of new technologies. Western Europe is expected to be the second large market in injectable drug delivery, with Germany, the U.K. and France occupying major shares. APEJ is expected to be third large market for injectable drug delivery, due to requirement of low capital for manufacturing injectable drug delivery.

Download Methodology of Report @ https://www.futuremarketinsights.com/askus/rep-gb-393

Key Research Findings

Increase in demand for point-of-care devices and reduced reliance on healthcare facilities are driving the growth of the global injectable drug delivery market

North America will be the dominant regional market for injectable drug delivery devices due to early adoption of advanced technologies

Most of the major players operate from the U.S., which makes the U.S. the leading market for injectable drug delivery devices in North America

In Europe, a large number of diabetes patients are switching towards needle-free injectable drug delivery devices from conventional injections since it is a painless process and reduces the risk of needle stick injuries

Disposable injectors are the most commonly available type of injectors since they are user friendly and do not require special skills for administration

Prefilled needle-free injectors are the most preferred type of injectors since they are much easier to administer than the fillable type

Price control for most of the injectable drug delivery devices is fierce. For instance, Mylan was pressurised to launch the generic version of the EpiPen to reduce the price of the product in the market. However, this has declined the revenue of the company.

In developed regions, such as North America and Europe, hospitals are the dominant distribution channel due in injectable drug delivery due to the reimbursement policies

The growing competition in the emerging market and the rising demand for injectable drug delivery are the future opportunities for the growth and expansion of the injectable drug delivery market.

Get Full Report Now @ https://www.futuremarketinsights.com/checkout/393

Injectable Drug Delivery Market Reports - Table of Contents

1. Executive Summary
2. Market Introduction
3. Injectable Drug Delivery Market Opportunity Analysis
4. Market Background
5. Global Economic Outlook
6. Key Inclusions
7. North America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
8. Eastern Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
9. Western Europe Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
10. Latin America Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
11. Asia Pacific excluding Japan and China (APEJC) Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
12. Japan Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
13. MEA Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028
14. Forecast Factors: Relevance and Impact
15. Forecast Assumptions
16. Competition Analysis
17. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Region
18. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Product
19. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Usage
20. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028, By Distribution Channel
21. Global Injectable Drug Delivery Market Analysis 2013–2017 and Forecast 2018–2028

Contact Us
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
T (UK): + 44 (0) 20 7692 8790
Sales: sales@futuremarketinsights.com
Press Office: Press@futuremarketinsights.com
Website: https:www.futuremarketinsights.com

ABOUT US:
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services, which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights, an aerial view of the competitive framework, and future market trends.

This release was published on openPR.